Chinese researchers develop immunotherapeutic agent for colon cancer
Time:2024-05-21 18:19:07 Source:politicsViews(143)
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
share to:
Previous:Pope trip to Luxembourg, Belgium confirmed for September, 2 weeks after challenging Asia visit
Next:Justin Timberlake set to bring his The Forget Tomorrow World Tour to Australia in 2025
Kind tips:The above content and pictures are compiled from the Internet and are for reference only. I hope they will be helpful to you! If there is any infringement, please contact us to delete it.!
You may also like
- Kevin Pillar gets 1,000th career hit in Angels' win at Texas
- Jennifer Lopez, 54, shares side
- Sudan's army chief urges for restoring membership in AU
- Chinese vice premier stresses timely delivery of homes to buyers
- With Djokovic awaiting the winner, Murray trails Hanfmann at rain
- Deborah Cox, 49, dazzles in a silver sequin gown as she glams up at star
- Hong Kong arrests 291 for endangering national security in past 4 years — Radio Free Asia
- 4th China International Consumer Products Expo opens to public
- Student fatally shot, suspect detained at Georgia's Kennesaw State University